Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Apr 01, 2021

SELL
$79.17 - $111.47 $161,427 - $227,287
-2,039 Closed
0 $0
Q3 2020

Nov 02, 2020

BUY
$81.91 - $134.94 $64,381 - $106,062
786 Added 62.73%
2,039 $211,000
Q2 2020

Aug 17, 2020

BUY
$54.33 - $89.52 $68,075 - $112,168
1,253 New
1,253 $99,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $581M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.